Get the Stockscreener App
4.70
0.00%
0.00
After Hours:
4.70
Evolent Health Inc stock is traded at $4.70, with a volume of 2.76M.
It is up +0.00% in the last 24 hours and up +18.69% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$4.70
Open:
$4.7
24h Volume:
2.76M
Relative Volume:
0.99
Market Cap:
$528.66M
Revenue:
$1.89B
Net Income/Loss:
$-496.52M
P/E Ratio:
-0.9874
EPS:
-4.7598
Net Cash Flow:
$1.40M
1W Performance:
-0.42%
1M Performance:
+18.69%
6M Performance:
+15.48%
1Y Performance:
-42.54%
1-Day Range:
$4.635
$4.815
1-Week Range:
$4.37
$4.905
52-Week Range:
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.70 | 528.66M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
163.38 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.14 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.56 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.66 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
67.81 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health Leads Healthcare Technology Sector Focus - Kalkine Media
Q1 2026 Earnings Season Results for Healthcare Technology for Providers StocksNews and Statistics - IndexBox
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $7 - Moomoo
Director Toyin Ajayi granted 41,096 RSUs at Evolent Health (EVH) - Stock Titan
Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units grant - Stock Titan
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant - Stock Titan
Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units award - Stock Titan
Director at Evolent Health (EVH) receives 41,096-share RSU grant - Stock Titan
Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings - Stock Titan
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Evolent Health Inc stock (US30050B1017): valuation metrics in focus after recent share price recover - AD HOC NEWS
Evolent Health Shareholders Approve Proposals at 2026 Meeting - The Globe and Mail
Evolent Health (EVH) holders back board, auditor and pay plan at 2026 meeting - Stock Titan
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - Quantisnow
3 Healthcare Stocks We Approach with Caution - Yahoo Finance
3 Reasons EVH is Risky and 1 Stock to Buy Instead - Yahoo Finance
Evolent Health(EVH) Stock Options Chain | Quotes & News - Moomoo
Evolent Health Q1 earnings call highlights - MSN
EVH Stock Price Prediction 2025-2026 | Evolent Health Inc Forecast - 24/7 Wall St.
Evolent Health : EVH - 24/7 Wall St.
Analysts’ Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH) - The Globe and Mail
WATER ISLAND CREDIT OPPORTUNITIES FUND's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health to Participate in Upcoming Conferences - GuruFocus
EVH Maintained by Citigroup -- Price Target Raised to $5.50 - GuruFocus
Citigroup Adjusts Price Target on Evolent Health to $5.50 From $4, Maintains Buy Rating - Moomoo
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $5.5 - Moomoo
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Evolent Health Q1 2026 beats EPS, stock surges - Investing.com UK
Evolent Health Price Target Raised to $6.00/Share From $4.00 by Canaccord Genuity - Moomoo
EVH Maintained by Canaccord Genuity -- Price Target Raised to $6 - GuruFocus
Evolent Health Is Maintained at Buy by Canaccord Genuity - Moomoo
CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
Canaccord raises Evolent Health stock price target on new wins By Investing.com - Investing.com South Africa
Canaccord raises Evolent Health stock price target on new wins - Investing.com
AI-focused health plan tools get new steward at Quest Analytics - Stock Titan
TD Cowen raises Evolent Health stock price target on recovery track - Investing.com UK
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $8 - Moomoo
TD Cowen raises Evolent Health stock price target on recovery track By Investing.com - Investing.com South Africa
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.22%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):